Norvir

The side effect potential of Norvir is much lower now that it is only used as a booster at low doses. Most common side effects include stomach pain, nausea, diarrhea, and vomiting. Other less common side effects may include fatigue; tingling/numbness around the mouth, hands, or feet; loss of appetite; and taste disturbances. Norvir can also increase cholesterol and triglyceride levels. Measure liver function before starting and then monitor, with perhaps closer monitoring for those with underlying liver problems, especially during the first several months. No dose adjustment necessary with mild to moderate liver disease, but Norvir is not recommended for those with severe liver impairment.

Norvir interacts with many drugs. Of note, Norvir is not interchangeable with Tybost. Also, Norvir tablets are not interchangeable with Norvir capsules. Do not take with alfuzosin, amiodarone, flecainide, lurasidone, propafenone, oral midazolam, triazolam, pimozide, ranolazine, Revatio, rifapentine, rifampin, voriconazole, ergot derivatives, or the herb St. John’s wort. Do not use lovastatin or sim-vastatin or co-formulations containing these drugs (Advicor and Vytorin) for the treatment of high cholesterol. Cholesterol-lowering alternatives are atorvastatin, rosuvastatin, pravastatin, pitavastatin, and fluva-statin, but should be used with caution and started at the lowest dose possible; monitor for increased side effects. Norvir increases levels of nasal and inhaled fluticasone (found in Advair, Flonase, Breo Ellipta, Arnuity Ellipta, and Flovent), which may lead to Cushing’s syndrome. Use an alternative corticosteroid and monitor for signs of Cushing’s syndrome (increased abdominal fat, fatty hump between the shoulders, rounded face, red/purple stretch marks, bone loss, possible high blood pressure, and sometimes diabetes). Trazodone concentrations may increase; a lower dose of trazodone is recommended. Norvir may decrease levels of methadone, therefore titrate dose of methadone to clinical effect. Use caution with anticonvulsants such as carbamazepine, phenobarbital, and phenytoin. Use calcium channel blockers (amlodipine, nifedipine, and others) with caution. Norvir may alter warfarin levels; additional monitoring is required. Norvir use with most other blood thinners (anticoagulants), such as Xarelto, is not recommended, however it can be used with apixaban (Eliquis) with monitoring and an adjusted dose of apixaban. Norvir can increase anticoagulant concentrations (and thereby increase risk of bleeding) or decrease their concentrations (and thereby decrease effectiveness). Cialis, Levitra, and Viagra levels are increased; doses should not exceed 10 mg Cialis or 2.5 mg Levitra per 72 hours, or 25 mg Viagra per 48 hours. Monitor for increased side effects of these medications, such as visual disturbances, low blood pressure, dizziness, and prolonged painful erection lasting longer than 4 hours. Effectiveness of oral contraceptives may be decreased; consider using other or alternative methods of contraception. Levels of the street drug ecstasy are greatly increased by Norvir, and at least one death has been attributed to the combination. Using Norvir with methamphetamines can result in up to 2–3-fold increase in methamphetamine concentrations and puts user at risk for overdose. GHB, another street drug, as well as cocaine are also dangerous with Norvir. Clarithromycin levels can increase by up to 80%. Co-administer bosentan, salmeterol, and immunosuppressants with caution. If co-administered, a lower dose of colchicine is recommended. Norvir, when combined with another PI, may be taken with Sovaldi, Daklinza (dose may need adjustment), Epclusa (monitor for tenofovir toxicity if TDF is part of regimen), and Harvoni (if TDF is not part of HIV regimen). Norvir + PI should not be taken with Olysio, Viekira Pak, or Zepatier. Tell your provider or pharmacist about all medications, herbals, and supplements you are taking or thinking of taking, prescribed or not, as there are other drug interactions which are not listed here.

Generic available.

The advantage of Norvir is its use at low doses with other PIs as a boosting agent (officially in the drug class called “pharmacokinetic enhancers”). As such, it’s used to increase the levels of some HIV protease inhibitor (PI) medications. Stomach side effects are reduced by taking Norvir with high-fat foods—however, some other HIV medicines should not be taken with high-fat foods.

Dr. Ross Slotten says:

The only reason to mention the protease inhibitor Norvir (ritonavir) is that its primary role today is as a boosting agent for other PIs like darunavir and atazanavir. It is no longer used as an agent to treat HIV (too large a pill burden when first approved in 1996). However, it is gradually being replaced by cobicistat, another boosting agent that can be combined into a single-tablet regimen with other agents. Because cobicistat has no anti-HIV activity, unlike ritonavir, there is no potential for inducing resistance to PIs.

Activist Bridgette Picou says:

Norvir is used as a booster in conjunction with protease inhibitors (PIs). It should not be taken alone. Although originally marketed for use as a PI treatment for HIV, the fact that it had disabling side effects on the gastrointestinal system and toxicity on the liver made it hard to tolerate long term. It was found however that at a lower dose and as a booster it could be used successfully with newer generation protease inhibitors. Norvir may increase the effects of some medications, including those taken over the counter, so discuss these with your doctor.